Pharmacologic therapies for obesity.

Lee M Kaplan

Journal: Gastroenterology clinics of North America 2010;39(1):69-79

PMID: 20202580

Full Text on Elsevier Science View on PubMed

Abstract

This article examines the transitions in pharmacological therapy for obesity. It reviews the current options approved by the Food and Drug Administration and several drugs approved for other indications that can be used to treat obesity as well. Because weight regulation is complex and redundant systems protect against perceived starvation, optimal treatment of obesity in individual patients will likely require different combinations of behavioral, nutritional, pharmacologic, endoscopic, and surgical therapies.

Address: MGH Weight Center and Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, 50 Staniford Street, Boston, MA 02114, USA. [email protected]

DOI: 10.1016/j.gtc.2010.01.001

Link outs

Free resources

Medical:

https://medlineplus.gov/obesity.html

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

MeSH Terms: Anti-Obesity Agents, Appetite Depressants, Bariatric Surgery, Benzazepines, Bupropion, Cyclobutanes, Ephedrine, Fenfluramine, Humans, Lactones, Naltrexone, Obesity, Orlistat, Phentermine, Weight Gain, Weight Loss